BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 16170024)

  • 1. Potentiation of paclitaxel-induced apoptosis by the novel cyclin-dependent kinase inhibitor NU6140: a possible role for survivin down-regulation.
    Pennati M; Campbell AJ; Curto M; Binda M; Cheng Y; Wang LZ; Curtin N; Golding BT; Griffin RJ; Hardcastle IR; Henderson A; Zaffaroni N; Newell DR
    Mol Cancer Ther; 2005 Sep; 4(9):1328-37. PubMed ID: 16170024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular determinants of epothilone B derivative (BMS 247550) and Apo-2L/TRAIL-induced apoptosis of human ovarian cancer cells.
    Griffin D; Wittmann S; Guo F; Nimmanapalli R; Bali P; Wang HG; Bhalla K
    Gynecol Oncol; 2003 Apr; 89(1):37-47. PubMed ID: 12694652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of survivin by retinoic acid and its role in paclitaxel-mediated cytotoxicity in MCF-7 breast cancer cells.
    Pratt MA; Niu MY; Renart LI
    Apoptosis; 2006 Apr; 11(4):589-605. PubMed ID: 16528475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent process.
    Yu C; Rahmani M; Dai Y; Conrad D; Krystal G; Dent P; Grant S
    Cancer Res; 2003 Apr; 63(8):1822-33. PubMed ID: 12702569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Induction effect of rapamycin combined paclitaxel on apoptosis of ovarian cancer cell lines A2780 and SKOV3 and the molecular mechanism].
    Ma XY; Wang SX; Liu Y; Liu RH; Lu YP; Ma D
    Ai Zheng; 2007 Apr; 26(4):367-70. PubMed ID: 17430653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of survivin in nitric oxide-induced cell growth inhibition and apoptosis of the human lung carcinoma cells.
    Chao JI; Kuo PC; Hsu TS
    J Biol Chem; 2004 May; 279(19):20267-76. PubMed ID: 14988404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence-dependent potentiation of paclitaxel-mediated apoptosis in human leukemia cells by inhibitors of the mitogen-activated protein kinase kinase/mitogen-activated protein kinase pathway.
    Yu C; Wang S; Dent P; Grant S
    Mol Pharmacol; 2001 Jul; 60(1):143-54. PubMed ID: 11408609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flavopiridol, a cyclin-dependent kinase inhibitor, enhances radiosensitivity of ovarian carcinoma cells.
    Raju U; Nakata E; Mason KA; Ang KK; Milas L
    Cancer Res; 2003 Jun; 63(12):3263-7. PubMed ID: 12810657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated E2F-1 gene transfer induces an apoptotic response in human gastric carcinoma cells that is enhanced by cyclin dependent kinase inhibitors.
    Atienza C; Elliott MJ; Dong YB; Yang HL; Stilwell A; Liu TJ; McMasters KM
    Int J Mol Med; 2000 Jul; 6(1):55-63. PubMed ID: 10851267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caspase-mediated Cdk2 activation is a critical step to execute transforming growth factor-beta1-induced apoptosis in human gastric cancer cells.
    Kim SG; Kim SN; Jong HS; Kim NK; Hong SH; Kim SJ; Bang YJ
    Oncogene; 2001 Mar; 20(10):1254-65. PubMed ID: 11313870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of antisense survivin-liposome complex on cell growth, apoptosis and cell cycle in hepatocellular carcinoma cells].
    Dai DJ; Wu D; Meng H; Lu CD
    Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):581-5. PubMed ID: 16438864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus-mediated inhibition of survivin expression sensitizes human prostate cancer cells to paclitaxel in vitro and in vivo.
    Zhang M; Mukherjee N; Bermudez RS; Latham DE; Delaney MA; Zietman AL; Shipley WU; Chakravarti A
    Prostate; 2005 Aug; 64(3):293-302. PubMed ID: 15754318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of survivin expression by taxol (paclitaxel) is an early event, which is independent of taxol-mediated G2/M arrest.
    Ling X; Bernacki RJ; Brattain MG; Li F
    J Biol Chem; 2004 Apr; 279(15):15196-203. PubMed ID: 14722122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphatidylinositol 3-kinase inhibition down-regulates survivin and facilitates TRAIL-mediated apoptosis in neuroblastomas.
    Kim S; Kang J; Qiao J; Thomas RP; Evers BM; Chung DH
    J Pediatr Surg; 2004 Apr; 39(4):516-21. PubMed ID: 15065019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxaliplatin, a potent inhibitor of survivin, enhances paclitaxel-induced apoptosis and mitotic catastrophe in colon cancer cells.
    Fujie Y; Yamamoto H; Ngan CY; Takagi A; Hayashi T; Suzuki R; Ezumi K; Takemasa I; Ikeda M; Sekimoto M; Matsuura N; Monden M
    Jpn J Clin Oncol; 2005 Aug; 35(8):453-63. PubMed ID: 16024531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single amino acid change (Asp 53 --> Ala53) converts Survivin from anti-apoptotic to pro-apoptotic.
    Song Z; Liu S; He H; Hoti N; Wang Y; Feng S; Wu M
    Mol Biol Cell; 2004 Mar; 15(3):1287-96. PubMed ID: 14699067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylseleninic acid enhances taxane drug efficacy against human prostate cancer and down-regulates antiapoptotic proteins Bcl-XL and survivin.
    Hu H; Li GX; Wang L; Watts J; Combs GF; Lü J
    Clin Cancer Res; 2008 Feb; 14(4):1150-8. PubMed ID: 18281549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteasome inhibitor 1 enhances paclitaxel-induced apoptosis in human lung adenocarcinoma cell line.
    Oyaizu H; Adachi Y; Okumura T; Okigaki M; Oyaizu N; Taketani S; Ikebukuro K; Fukuhara S; Ikehara S
    Oncol Rep; 2001; 8(4):825-9. PubMed ID: 11410792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of survivin in G2/M cells and inhibition of caspase 9 activity enhances resistance in staurosporine-induced apoptosis.
    Chandele A; Prasad V; Jagtap JC; Shukla R; Shastry PR
    Neoplasia; 2004; 6(1):29-40. PubMed ID: 15068669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes of survivin mRNA and protein expression during paclitaxel treatment in breast cancer cells.
    Xiong H; Yu S; Zhuang L; Xiong H
    J Huazhong Univ Sci Technolog Med Sci; 2007 Feb; 27(1):65-7. PubMed ID: 17393113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.